AMENDMENT NUMBER ELEVEN TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT
Exhibit 10.02
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [******], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.
AMENDMENT NUMBER ELEVEN
This AMENDMENT NUMBER ELEVEN TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT (“Amendment”) is made effective as of March 15, 2023 (“Amendment Effective Date”) by and between DexCom, Inc. (“DexCom”) and RGH Enterprises, LLC dba Edgepark Medical Supplies (“Distributor”). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.
RECITALS
WHEREAS, XxxXxx and Distributor previously entered into that certain Non-Exclusive Distribution Agreement entered into by the Parties as of April 30, 2008 (as the same has been and may be amended from time to time, the “Agreement”);
WHEREAS, XxxXxx and Distributor desire to further amend the Agreement, as more fully described herein.
AGREEMENT
NOW THEREFORE, XxxXxx and Distributor agree as follows:
1.Schedule 9, Market Share Report. Schedule 9, including Schedule 9-A, which is attached hereto, is hereby added to the Agreement.
2.No Further Modification. Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.
[Remainder of Page Intentionally Blank;
Signature Page Follows]
Signature Page Follows]
IN WITNESS WHEREOF, the parties have executed this Amendment effective as of the Amendment Effective Date.
| DexCom, Inc. | Distributor | |||||||||||||
| By: | /s/ Xxxxxxxxxx Xxxxxxxx | By: | /s/ Xxxxxx Xxxxxx | |||||||||||
| Name: | Xxxxxxxxxx Xxxxxxxx | Name: | Xxxxxx Xxxxxx | |||||||||||
| Title: | VP, Finance and Corporate Controller | Title: | Senior Director, Strategic Sourcing | |||||||||||
| Date: | 4/4/2023 | Date: | 3/23/2023 | |||||||||||
SCHEDULE 9
DexCom Market Share Report
[******]
SCHEDULE 9-A
DexCom Market Share Report Format
[******]
